NCT01825148View on ClinicalTrials.gov

GLP-1 Receptor Targeting in Diabetic and Healthy Individuals

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Type 1 Diabetes
Interventions
OTHER

radiolabeled Exendin

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01825148 - GLP-1 Receptor Targeting in Diabetic and Healthy Individuals | Biotech Hunter | Biotech Hunter